Jiangsu Jibeier Pharmaceutical Co Ltd (688566) — Capital Reinvestment Ratio
Jiangsu Jibeier Pharmaceutical Co Ltd (688566) has a Capital Reinvestment Ratio of 2.24x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥11.07 Million) in capital expenditures (CN¥24.80 Million). See Jiangsu Jibeier Pharmaceutical Co Ltd net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jiangsu Jibeier Pharmaceutical Co Ltd Capital Reinvestment Ratio (2016–2025)
This chart tracks Jiangsu Jibeier Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 10 annual periods. Check Jiangsu Jibeier Pharmaceutical Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Jiangsu Jibeier Pharmaceutical Co Ltd (2016–2025)
Year-by-year Capital Reinvestment Ratio for Jiangsu Jibeier Pharmaceutical Co Ltd from 2016 to 2025. For live market cap and broader valuation context, see 688566 market cap.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.46x | CN¥248.30 Million | CN¥114.60 Million | ▼ -43.1% |
| 2024 | 0.81x | CN¥215.29 Million | CN¥174.53 Million | ▼ -63.8% |
| 2023 | 2.24x | CN¥159.50 Million | CN¥357.37 Million | ▲ +15.4% |
| 2022 | 1.94x | CN¥150.72 Million | CN¥292.70 Million | ▲ +249.0% |
| 2021 | 0.56x | CN¥150.56 Million | CN¥83.79 Million | ▲ +175.8% |
| 2020 | 0.20x | CN¥117.36 Million | CN¥23.68 Million | ▼ -22.9% |
| 2019 | 0.26x | CN¥115.45 Million | CN¥30.22 Million | ▲ +212.9% |
| 2018 | 0.08x | CN¥97.97 Million | CN¥8.19 Million | ▼ -50.3% |
| 2017 | 0.17x | CN¥111.66 Million | CN¥18.78 Million | ▼ -85.8% |
| 2016 | 1.19x | CN¥39.29 Million | CN¥46.69 Million | — |